Search Results
DDx Strength: Moderate
risankizumab, Rash or multiple lesions, 50-59 year old Female

Edit Findings
PsoriasisPsoriasis
Acute febrile neutrophilic dermatosisAcute febrile neutrophilic dermatosis
Pustular psoriasisPustular psoriasis
Adverse cutaneous reactions to targeted biologic therapies
Drug-induced fatigue
Drug-induced headache